Mortality with Paclitaxel-Coated Devices in Peripheral Artery Disease

Interim analysis of a multicenter, randomized, clinical trial (Swedish Drug Elution Trial in Peripheral Arterial Disease) between November 5, 2014, and December 10, 2018. About one-half of almost 2300 patients were treated with paclitaxel-coated devices and one-half with uncoated devices. Approximately 25% of patients died in each group during a mean follow-up of 2.5 years. During the entire follow-up period, there was no significant difference...